Mountain Valley to proceed with pre-clinical cancer trials, files related cancer patent

  • Mountain Valley MD Holdings (OTCQB:MVMDF) has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials in triple-negative breast cancer, metastatic melanoma, and lung carcinoma.
  • The patent-pending adjuvant utilizes the company's advances in macrocyclic lactone solubility to consider

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.